David Gaiero
Direttore Finanziario/CFO presso CYTEIR THERAPEUTICS, INC.
Patrimonio netto: 308 197 $ in data 31/03/2024
Profilo
David Gaiero is currently the Chief Financial Officer & Treasurer at Cyteir Therapeutics, Inc. and the Chief Financial & Accounting Officer at Imunon, Inc. He is also a Partner at Monomoy Advisors LLC.
Previously, he held the position of Chief Financial & Accounting Officer at Wave Life Sciences Ltd.
and Vice President & Global Controller at OvaScience, Inc. Mr. Gaiero completed his undergraduate degree at the University of Massachusetts.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 04/03/2024 | 102 391 ( 0.28% ) | 308 197 $ | 31/03/2024 |
Posizioni attive di David Gaiero
| Società | Posizione | Inizio |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/12/2020 |
| IMUNON, INC. | Direttore Finanziario/CFO | 01/06/2024 |
| Monomoy Advisors LLC | Corporate Officer/Principal | - |
Precedenti posizioni note di David Gaiero
| Società | Posizione | Fine |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Direttore Finanziario/CFO | 04/12/2020 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | 01/01/2017 |
Formazione di David Gaiero
| University of Massachusetts | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| WAVE LIFE SCIENCES LTD. | Health Technology |
| IMUNON, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
| Monomoy Advisors LLC |
- Borsa valori
- Insiders
- David Gaiero
